Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 6
- Medical Cannabis
UK Medical Cannabis Under Review: Where is the ACMD Report?
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
- Data & Analysis
Cannabis Legalisation in the UK: Where the Law Actually Stands and What Could Change
In the UK, cannabis remains a Class B drug under the Misuse of Drugs Act 1971, meaning the possession, supply and cultivation for recreational purposes are all criminal offences carrying significant potential sentences.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
- Cultivation
Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
- UK & Europe
Portugal’s Regulator Defends Cannabis Crackdown as Export Permit Delays Fall
Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
- CBD Market
FSA Backs Britain’s First CBD Food Authorisations as Brexit Deal Threatens to Override Them
Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications for ministerial approval in a move that could bring an estimated 3,000 products into legal compliance.
- CBD Market
French Trade Groups Prepare For Key CBD Ruling
Despite the Council of State knocking back its initial attempt to derail the French authorities’ latest crackdown on CBD, the head of the trade groups fighting the ban remain upbeat on its chances of success.
- M&A Activity
Curaleaf & Aurora’s Takeover Battle: Votes, Valuations and Vitriol
Curaleaf Holdings’s takeover bid for its Canadian rival Aurora Cannabis has evolved into a public spat between the two cannabis giants over whose financial projections are honest, who would actually control the proposed new entity, and whether the current bid can even close on its own terms.
- Clinical Research
The Company That Wants to Make the Endocannabinoid System as Measurable as Blood Sugar
Dr Stefan Broselid, Founder and Scientific Lead of ECS Restore, has filed a patent application for a non-cannabinoid formulation designed to treat dysfunction in the endocannabinoid system (ECS), moving his research from scientific hypothesis towards a meaningful commercial proposition.
- Data & Analysis
Is Cannabis Legal in Germany in 2026? The Law, the Market and What It Means for Operators
Is cannabis legal in Germany? No, not in the way it is in the majority of US states or Canada.
- International Regulation
Australia’s Medical Cannabis Reforms to Target ‘Closed Loop’ Prescribing
Australia’s ongoing efforts to restrict its medical cannabis market, now the largest outside North America, are now taking aim at the special access scheme (SAS) framework on which the country’s hundreds of thousands of annual prescriptions are based.
- Industry Trends
What’s in Store for the Global Cannabis Industry in 2026? Mid-Year Update
This article was updated on September 02, 2026 In December 2025, we asked our in-house team of experts how they expected to see the industry evolve over the coming year.
